NABIH I. ABDOU, M.D., Ph.D.; NANCY L. ABDOU, M.D.
Despite the increased amounts of serum immunoglobulins (Ig) in multiple myeloma, the percentage of bone marrow-dependent (B) cells carrying surface Ig in the peripheral blood compartment were decreased, when compared with that in control patients with polyclonal gammopathy or with that in normals (5 ±2% in patients with multiple myeloma and 19 ±5% or 22 ±7% in controls). Most circulating B cells in patients with multiple myeloma were shown to carry individually specific idiotypic Ig. The monoclonal idiotypic nature of the surface Ig was shown by using antiserums raised against the monoclonal Ig. The idiotypic antiserum was capable of actively binding to and stimulating the idiotypic lymphocytes to divide in vitro. Commercial anti-Ig antiserums raised against normal Ig did not bind to the myeloma lymphocytes. After chemotherapy, lymphocytes carrying the idiotypic Ig decreased in numbers, and this correlated with other variables of clinical improvement. Its role in the pathogenesis of myeloma and its importance for diagnosis and follow-up of patients with myeloma are discussed.
ABDOU NI, ABDOU NL. The Monoclonal Nature of Lymphocytes in Multiple Myeloma: Effects of Therapy. Ann Intern Med. ;83:42–45. doi: 10.7326/0003-4819-83-1-42
Download citation file:
Published: Ann Intern Med. 1975;83(1):42-45.
Hematology/Oncology, Multiple Myeloma.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use